Related Experiment Video
Updated: Jun 5, 2025

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Interventions to enhance corporate sector engagement in tuberculosis response in Africa: a scoping review protocol
Olubunmi Margaret Ogbodu1, Busisiwe Mrara2, Olanrewaju Oladimeji3
1Department of Anaesthesiology and Critical Care, Faculty of Health Sciences, Walter Sisulu University - Mthatha Campus, Mthatha, South Africa olubunmi.margaret9@gmail.com.
Introduction:
Tuberculosis (TB) is a significant public health crisis in Africa. TB control programmes implemented by various state and non-state actors in different African countries over the years have recorded significant gains in the reduction of the incidence and prevalence of TB through the vehicle of private care provider engagement in the diagnosis, treatment and care. However, the corporate sector, which often represents a large pool of resources and access to individuals, is neglected or underestimated in the public-private mix of TB control efforts. Employees, clients and suppliers in the corporate sector network are a group of individuals who could have been unreached through the available public and private care provider structures but remain unreached even when these individuals may be uninformed about TB and its transmission mechanism in the workplace. Such individuals, if infected, are unaware of symptoms, remain undetected and untreated or may be handled by different healthcare professionals without the national TB programme framework without being informed for record and capturing purposes because TB is a notifiable disease. Thus, such data on TB incidence will be lost. Collaboration with corporate firms to enhance the prevention, diagnosis and treatment of TB through preventive interventions holds great potential for a complementary role in building resilient public healthcare systems by harnessing resources to meet target 3.3 of the United Nations Sustainable Development Goals to eradicate the prevalence of AIDS, TB, malaria as well as neglected tropical diseases. To increase private sector involvement in the fight against TB in Africa, a scoping assessment has been recommended to outline and explain the scientific proof of initiatives. The possibility for guiding prospective studies and actions focused on generating specific measures to improve private sector involvement in tackling the deficiencies in TB responsiveness in Africa can be achieved through synthesising and disseminating current data in this area. The research aims to explore and describe the evidence of the interventions to enhance corporate sector engagement in TB response in Africa.
Methodology:
Using the well-established scoping review methodology outlined by the Joanna Briggs Institute, a five-stage review is outlined: (1) determining the research question, (2) search strategy, (3) inclusion criteria, (4) data extraction and (5) analysis and presentation of the results.The literature search will use PubMed, SCOPUS and the Cumulative Index to Nursing and Allied Health Literature search interfaces, reflecting empirical and grey literature. We will focus on literature published between 2014 and 2024. A two-stage screening process will be used to determine the eligibility of articles. All articles will be individually assessed, for eligibility by two reviewers, while any disagreements will be resolved by a third reviewer in making a decision. The data from eligible articles will be extracted and charted using a standardised form while the extracted data will be analysed using narrative and descriptive analyses.
Ethics And Dissemination:
Ethical approval is not required for this scoping review. The results of this search will be disseminated through peer-reviewed publications and academic presentations at local, national and international conferences.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
International Nursing Organizations II
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

